The Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA).
Invited as expert for the presentation of the SALT study results at the CHMP hearing meeting for Art. 31 for nimesulide. May 17th 2011, London, the United Kingdom.
La Haute Autorité de Santé, Commission de la Transparence.
Invited as expert for the presentation of the results French part of the SALT study at the meeting held on May 11th 2011, Paris, France.